Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1511694
Reference Type
Journal Article
Title
Hereditary gingival fibromatosis associated with generalized aggressive periodontitis: a case report
Author(s)
Casavecchia, P; Uzel, MI; Kantarci, A; Hasturk, H; Dibart, S; Hart, TC; Trackman, PC; Van Dyke, TE
Year
2004
Is Peer Reviewed?
Yes
Journal
Journal of Periodontology
ISSN:
0022-3492
EISSN:
1943-3670
Volume
75
Issue
5
Page Numbers
770-778
Language
English
PMID
15212361
DOI
10.1902/jop.2004.75.5.770
Web of Science Id
WOS:000221560100020
Abstract
BACKGROUND:
Hereditary gingival fibromatosis is a rare, genetically inherited overgrowth condition that is clinically characterized by a benign fibrous enlargement of maxillary and mandibular keratinized gingiva. A syndromic association between gingival fibromatosis and a wide variety of other genetically inherited disorders has been described. However, its coexistence with aggressive periodontitis has not been reported.
METHODS:
A 24-year-old African-American female, patient (proband X, [Px]) reported with a chief complaint of tooth mobility and gingival enlargement. Clinical examination revealed moderate to severe gingival overgrowth on both mandible and maxilla. Generalized attachment loss and mobility of the teeth were observed. Radiographic evaluation demonstrated severe alveolar bone loss. The patient was diagnosed with gingival fibromatosis and aggressive periodontitis based on the clinical and radiographic findings. Her brother (Bx) and her mother (Mx) were evaluated and diagnosed with gingival fibromatosis suggesting that this is a dominant trait in the family and gingival fibromatosis might be of hereditary origin. In addition, the brother also exhibited localized aggressive periodontitis. Medical history revealed no other systemic or local contributory factors associated with the oral findings in any of the subjects.
RESULTS:
Surgical therapy included internal bevel gingivectomy combined with open flap debridement procedures for Px and Bx. Only internal bevel gingivectomy was performed for Mx since there was mild bone resorption and no intrabony defects. At the time of surgery, gingival biopsies were obtained and fixed in 4% paraformaldehyde. Multiple serial sections were stained with hematoxylin and eosin. Microscopic evaluation of the gingival specimens revealed large parallel collagen bundles associated with scarce fibroblasts in the connective tissue. The collagen bundles reached into the subepithelial connective tissue where elongated rete-pegs were also observed. Following the completion of the treatment, no signs of recurrence or bone resorption were observed over 2-year follow-up.
CONCLUSIONS:
This is the first report of hereditary gingival fibromatosis associated with aggressive periodontitis. Combined treatment comprising removal of fibrotic gingival tissue and traditional flap surgery for the elimination of intrabony defects represents a unique treatment approach in periodontal therapy. Two-year follow-up revealed that both the gingival overgrowth and the destructive lesions were successfully treated.
Keywords
Adult; Alveolar Bone Loss/etiology; Fibromatosis, Gingival/ genetics; Follow-Up Studies; Gingivectomy; Periodontal Attachment Loss/etiology; Periodontitis/ complications; Surgical Flaps; Tooth Mobility/etiology
Tags
IRIS
•
Formaldehyde [archived]
Nervous system effects
Found
Database search results
PubMed
Screened
Title/abstract
Case study
Reproductive and Developmental Effects
Screened
Title/abstract
Methodology/therapeutics
Retroactive RIS import
Pre2013
Merged Litsearch Results 100912
Merged LitSearch Results ToxNet 101012
Merged LitSearch Additions 86 Reviews SCREEN
PubMed Search 100912
2013
HCHON tox Ref Identification 022713
2015
FA DevRepro 072115
Methodology/Therapeutics-Population Criteria
•
IRIS Formaldehyde (Inhalation) [Final 2024]
Literature Indexing
PubMed
Literature Identification
Nervous System Effects
Excluded
Reproductive and Developmental Effects
Excluded
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity